✦ LIBER ✦

Orchidectomy versus Zoladex® plus Eulexin® in patients with metastatic prostate cancer (EORTC 30853)

✍ Scribed by Denis, L.; Robinson, M.; Mahler, C.; Smith, Ph.; Keuppens, F.; Carneiro De Moura, J.L.; Bono, A.; Newling, D.; Sylvester, R.; De Pauw, M.

Book ID: 123583056
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 587 KB
Volume: 37
Category: Article
ISSN: 0960-0760
DOI: 10.1016/0960-0760(90)90449-U

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Orchidectomy versus goserelin plus fluta

Orchidectomy versus goserelin plus flutamide in patients with metastatic prostate cancer (EORTC 30853)

✍ F. Keuppens; P. Whelan; J. L. De Carneiro Moura; D. Newling; A. Bono; L. Denis; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

Orchidectomy versus buserelin in combina

Orchidectomy versus buserelin in combination with CPA for 2 weeks or continuously in the treatment of metastatic prostate cancer (EORTC 30843)

✍ de Voogt, HJ 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 130 KB

Quality-adjusted survival (Q-TWiST) anal

Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: Comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer

✍ Rosendahl, Ingvar; Kiebert, Gwendoline M.; Curran, Desmond; Cole, Bernhard F.; W 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

## Background: The first data analysis of the european organization for research and treatment of cancer (eortc) 30853 trial indicated a significantly longer time to progression and duration of survival for the maximal androgen blockade (mab) treatment arm. however, the mab treatment arm had a high

PP53. A quality-adjusted survival (Q-TWI

PP53. A quality-adjusted survival (Q-TWIST) analysis of EORTC trial 30853 comparing maximal androgen blockade (MAB) with orchiectomy in patients with metastatic prostate cancer

✍ KI Rosendahl; D Curran; G Kiebert; B Cole; JC Weeks; LJ Denis; RR Hall 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Orchidectomy versus buserelin in combina

Orchidectomy versus buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-trial 30843

✍ de Voogt, H.J.; Klijn, J.G.M.; Studer, U.; Schröder, F.; Sylvester, R.; De Pauw, 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Intermittent Maximal Androgen Blockade i

Intermittent Maximal Androgen Blockade in Patients with Metastatic Prostate Cancer: An EORTC Feasibility Study

✍ Walter Albrecht; Laurence Collette; Cesare Fava; Oleg B. Kariakine; Peter Whelan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB